Abstract
Introduction

41
The incidence of pulmonary infections caused by non-tuberculous mycobacteria 42 (NTM) has increased dramatically worldwide in recent years (1-3). Among them, 43 Mycobacterium abscessus (M. abscessus) infections are the most difficult to manage 44 (4, 5) . M. abscessus infections, which are even refractory to combined, long-term 45 antibiotic therapy, often result in mortality. consisted of intravenous amikacin, tigecycline, and imipenem with a macrolide, e.g., 52 clarithromycin, for the initial treatment phase (7). This was followed by a linezolid and tigecycline, were not used or administered in very few cases. Moreover, 68 despite identifying the antibiotics most effective, the adverse effects of these 69 antibiotics were not considered. 70 We previously reported a series of studies demonstrating the antibiotic 
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